Full Breakdown
Christina Applegate’s Reversal of an MS Diagnosis Highlights Ongoing Challenges in Multiple Sclerosis Diagnosis
By Drooid · · How we work
Core Event
On the “MeSsy” podcast released October 20, actress Christina Applegate announced that her physician had determined she does not have multiple sclerosis (MS), overturning a 2021 diagnosis. She said the news left her “back at square one,” noting that pain, weakness and fatigue persist. The reversal followed a re-evaluation of her brain MRI with newer imaging techniques.
Diagnostic Process and Challenges
MS diagnosis relies on clinical presentation, MRI of the brain and spinal cord, and, when needed, cerebrospinal-fluid analysis; no single test definitively confirms the disease. Dr. Yohance Allette described MS as essentially a diagnosis of exclusion.
Misdiagnosis Rates and Data
Analyses of patients referred to specialty MS centers show varying misdiagnosis rates:
- A 2024 review of six studies found 15 % of 1,621 patients initially diagnosed with MS were later re-classified.
- A 2019 Los Angeles study reported ?18 % misdiagnosis among 241 patients.
- Dr. Kaisey cited “almost one in five” patients who were later found not to have MS.
These differences stem from patient populations, diagnostic criteria and the use of advanced imaging such as the “central vein sign,” which helps separate true MS lesions from other white-matter abnormalities.
Implications for Patients and Care
- Treatment Risks: Unnecessary exposure to disease-modifying drugs can cause side-effects without benefit.
- Psychological Impact: Removing the MS label can be “earth-shattering” for patients who have identified with the community.
- Financial Consequences: Disability benefits and insurance tied to an MS diagnosis may be jeopardized.
Early, accurate diagnosis remains vital because timely therapy can delay disability progression. Dr. Ari Green noted that modern treatments have shifted typical disability onset from a decade to three-four decades after symptom onset.
Expert Commentary
Neurologists stress specialist evaluation and vigilance:
- Dr. Richard Ransohoff called the central-vein sign “a real step forward” in lesion differentiation.
- Dr. Michael Kornberg (Johns Hopkins) advised seeking second opinions when results seem atypical.
- Dr. Juvinall warned that “there is not a single blood test or MRI finding that definitively tells you this is MS,” recommending referral to an MS-designated center.
Conflicting Reports & Gaps
Published misdiagnosis rates range from 5 % to over 40 %, varying by study design and clinical setting. No consensus exists on the exact prevalence, and the impact of newer imaging on reducing errors remains uncertain.
Verbatim Quotes
- “To distinguish MS from its mimics can be challenging, and doctors, even with the best intentions …” — Dr. Marwa Kaisey, Cedars-Sinai
- “Ultimately, it's a diagnosis of exclusion,” — Dr. Yohance Allette, Penn State Health
- “Almost one in five of these people who’d been told they had MS, some for decades, didn’t actually have it.” — Dr. Marwa Kaisey
- “There was some new technology that came out that was checking the brain MRIs, comparing them to other people,” — Christina Applegate, “MeSsy” podcast
These statements illustrate diagnostic uncertainty, recent technological advances, and the broader impact on patients like Applegate.